Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML
暂无分享,去创建一个
S. Mustjoki | I. Glauche | I. Roeder | S. Jilg | F. Mahon | F. Guilhot | P. Jost | C. Baldow | J. Guilhot | S. Saussele | A. C. Fassoni | Tom Hähnel | S. Dulucq | Christoph Baldow